Klomp consolidates power at HHS, oversees FDA leadership shuffle

President Trump's nomination of Chris Klomp as deputy secretary of HHS cements the authority of an official who has effectively been running the department since February, and who is now reshaping FDA.

Klomp is leading the search for a new commissioner, along with a parallel search for permanent CDER and CBER directors. According to individuals who have spoken with him, Klomp is considering a two-tier structure at FDA that could pair a commissioner with political credibility among MAHA and conservative constituencies with a deputy commissioner for medical products who would handle regulatory matters. ...